PRTG250117C2500
- 0.15
- 0.000.00%
Portage Biotech Newsroom
Portage Biotech Inc. Reports Asset and Liability Changes
Portage Biotech Reports Reduced Losses and Strategic Plans
Express News | Portage Biotech: Adport-601 Trial Is Paused for Further Patient Accrual Pending Additional Financial Resources
Express News | Portage Biotech: Continuing to Explore Multiple Strategic Alternatives
Portage Biotech Reports Q2 EPS ($1.26) Vs. ($5.80) Last Year
Portage Biotech 2Q Loss/Shr $1.26 >PRTG
Express News | Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
Press Release: Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With Losses
Portage Biotech Welcomes New Financial Leadership
Express News | Portage Biotech Inc - on Sept 30, Andrea Park, as Chief Financial Officer Joined Co
Express News | Portage Biotech: On Sept 30, Allan Shaw, CFO Departed From Co
Trending Stocks Today | Portage Biotech Surges 154.3%
Top Premarket Gainers
Trending Stocks Today | Portage Biotech Shoots up 121.85% Pre-Market
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Express News | Portage Biotech : Regains Compliance With Nasdaq Listing Rule 5550(a)(2)
12 Health Care Stocks Moving In Monday's Intraday Session
Portage Biotech Reports Decreased Quarterly Loss
Express News | Portage Biotech Shares Down 4.2% Premarket After Reporting Q1 Share Loss, Says Still Exploring Strategic Alternatives